191 related articles for article (PubMed ID: 8387272)
1. The uptake of 3H-labelled monodeoxyfluoro-myo-inositols into thymocytes and their incorporation into phospholipid in permeabilized cells.
Offer J; Metcalfe JC; Smith GA
Biochem J; 1993 Apr; 291 ( Pt 2)(Pt 2):553-60. PubMed ID: 8387272
[TBL] [Abstract][Full Text] [Related]
2. Effects of fluorinated inositols on the phosphoinositide metabolism and the proliferation of Trypanosoma cruzi.
Einicker-Lamas M; Malaquias AT; de Castro SL; Smith GA; Oliveira MM
Parasitol Res; 1999 Mar; 85(3):232-8. PubMed ID: 9951967
[TBL] [Abstract][Full Text] [Related]
3. Studies of inositol analogues as inhibitors of the phosphoinositide pathway, and incorporation of 2-deoxy-2-fluoro-myo-inositol to give analogues of phosphatidylinositol intermediates.
McPhee F; Downes CP; Lowe G
Biochem J; 1991 Jul; 277 ( Pt 2)(Pt 2):407-12. PubMed ID: 1650182
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of 3-modified 1D-myo-inositols as inhibitors and substrates of phosphatidylinositol synthase and inhibitors of myo-inositol uptake by cells.
Johnson SC; Dahl J; Shih TL; Schedler DJ; Anderson L; Benjamin TL; Baker DC
J Med Chem; 1993 Nov; 36(23):3628-35. PubMed ID: 8246231
[TBL] [Abstract][Full Text] [Related]
5. D-3-deoxy-3-substituted myo-inositol analogues as inhibitors of cell growth.
Powis G; Aksoy IA; Melder DC; Aksoy S; Eichinger H; Fauq AH; Kozikowski AP
Cancer Chemother Pharmacol; 1991; 29(2):95-104. PubMed ID: 1760864
[TBL] [Abstract][Full Text] [Related]
6. Substrate properties of analogs of myo-inositol.
Moyer JD; Reizes O; Ahir S; Jiang C; Malinowski N; Baker DC
Mol Pharmacol; 1988 Jun; 33(6):683-9. PubMed ID: 2837638
[TBL] [Abstract][Full Text] [Related]
7. Fluorinated cyclitols as useful biological probes of phosphatidylinositol metabolism.
Schedler DJ; Baker DC
Carbohydr Res; 2004 Jun; 339(9):1585-95. PubMed ID: 15183732
[TBL] [Abstract][Full Text] [Related]
8. The 5-hydroxyl of myo-inositol is essential for uptake into HSDM1C1 mouse fibrosarcoma cells.
Auchus RJ; Wilson DB; Covey DF; Majerus PW
Biochem Biophys Res Commun; 1985 Aug; 130(3):1139-46. PubMed ID: 4026861
[TBL] [Abstract][Full Text] [Related]
9. Cellular pharmacology of D-3-azido-3-deoxy-myo-inositol, an inhibitor of phosphatidylinositol signaling having antiproliferative activity.
Brunn G; Fauq AH; Chow S; Kozikowski AP; Gallegos A; Powis G
Cancer Chemother Pharmacol; 1994; 35(1):71-9. PubMed ID: 7987980
[TBL] [Abstract][Full Text] [Related]
10. In vivo chiro-inositol metabolism in the rat: a defect in chiro-inositol synthesis from myo-inositol and an increased incorporation of chiro-[3H]inositol into phospholipid in the Goto-Kakizaki (G.K) rat.
Pak Y; Hong Y; Kim S; Piccariello T; Farese RV; Larner J
Mol Cells; 1998 Jun; 8(3):301-9. PubMed ID: 9666467
[TBL] [Abstract][Full Text] [Related]
11. Insulin stimulates the biosynthesis of chiro-inositol-containing phospholipids in a rat fibroblast line expressing the human insulin receptor.
Pak Y; Paule CR; Bao YD; Huang LC; Larner J
Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7759-63. PubMed ID: 8356081
[TBL] [Abstract][Full Text] [Related]
12. myo-inositol transport and metabolism in fetal-bovine aortic endothelial cells.
Berry GT; Johanson RA; Prantner JE; States B; Yandrasitz JR
Biochem J; 1993 Nov; 295 ( Pt 3)(Pt 3):863-9. PubMed ID: 8240303
[TBL] [Abstract][Full Text] [Related]
13. Radiosynthesis and in vivo tumor uptake of 2-deoxy-2-[(18)F]fluoro-myo-inositol.
Carroll L; Perumal M; Vasdev N; Robins E; Aboagye EO
Bioorg Med Chem Lett; 2012 Oct; 22(19):6148-50. PubMed ID: 22944120
[TBL] [Abstract][Full Text] [Related]
14. Sodium-dependent uptake of [3H]scyllo-inositol by Tetrahymena: incorporation into phosphatidylinositol, phosphatidylinositol-linked glycans, and polyphosphoinositols.
Ryals PE; Kersting MC
Arch Biochem Biophys; 1999 Jun; 366(2):261-6. PubMed ID: 10356291
[TBL] [Abstract][Full Text] [Related]
15. Effects of fluorinated inositols on the proliferation of Swiss 3T3 fibroblasts.
Cosulich SC; Offer J; Smith GA; Hesketh R; Metcalfe JC
Biochem J; 1993 Jun; 292 ( Pt 3)(Pt 3):719-24. PubMed ID: 8318004
[TBL] [Abstract][Full Text] [Related]
16. Manganese-stimulated phosphatidylinositol headgroup exchange in rat liver microsomes.
Irvine RF
Biochim Biophys Acta; 1998 Aug; 1393(2-3):292-8. PubMed ID: 9748635
[TBL] [Abstract][Full Text] [Related]
17. Effects of a water-soluble antitumor ether phosphonoinositide, D-myo-inositol 4-(hexadecyloxy)-3(S)-methoxybutanephosphonate (C4-PI), on inositol lipid metabolism in breast epithelial cancer cell lines.
Lin W; Leung LW; Bae YS; Bittman R; Arthur G
Biochem Pharmacol; 1999 May; 57(10):1153-8. PubMed ID: 11230803
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 2-deoxy-2-C-alkylglucosides of myo-inositol as possible inhibitors of a N-deacetylase enzyme in the biosynthesis of mycothiol.
Gammon DW; Hunter R; Steenkamp DJ; Mudzunga TT
Bioorg Med Chem Lett; 2003 Jun; 13(12):2045-9. PubMed ID: 12781192
[TBL] [Abstract][Full Text] [Related]
19. Restoration of Na(+)-K+ pump activity and resting membrane potential by myo-inositol supplementation in neuroblastoma cells chronically exposed to glucose or galactose.
Yorek MA; Dunlap JA; Stefani MR
Diabetes; 1991 Feb; 40(2):240-8. PubMed ID: 1846827
[TBL] [Abstract][Full Text] [Related]
20. L-fucose is a potent inhibitor of myo-inositol transport and metabolism in cultured neuroblastoma cells.
Yorek MA; Dunlap JA; Stefani MR; Davidson EP
J Neurochem; 1992 May; 58(5):1626-36. PubMed ID: 1313850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
